Australia markets closed

CureVac N.V. (5CV.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.1760+0.0760 (+3.62%)
As of 06:36PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
42,880
67,420
102,990
48,871
Cost of revenue
150,770
183,993
238,195
14,173
Gross profit
-107,890
-116,573
-135,205
34,698
Operating expenses
Research development
109,979
62,550
815,907
113,808
Selling general and administrative
78,418
89,411
88,857
45,663
Total operating expenses
201,248
134,279
277,058
144,513
Operating income or loss
-309,138
-250,852
-412,263
-109,815
Interest expense
7,449
3,707
10,338
22,103
Total other income/expenses net
1,436
1,395
-
-
Income before tax
-302,231
-249,155
-412,498
-129,848
Income tax expense
67
-126
-782
-726
Income from continuing operations
-302,298
-249,029
-411,716
-129,122
Net income
-302,298
-249,029
-411,716
-129,122
Net income available to common shareholders
-302,298
-249,029
-411,716
-129,122
Basic EPS
-1.47
-1.32
-2.21
-0.98
Diluted EPS
-1.47
-1.32
-2.21
-0.98
Basic average shares
212,896
189,075
186,013
132,196
Diluted average shares
212,896
189,075
186,013
132,196